Last reviewed · How we verify
NCT04600648
Sweet Taste Responsiveness in Relation to Insulin, Leptin and Adiposity Among Obese Treatment Seeking Children
NA trial testing Serum insulin level in Pediatric Obesity. Withdrawn.
2 August 2019
Quick facts
| Lead sponsor | State University of New York at Buffalo |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Start date | 20 September 2018 |
| Primary completion | 2 August 2019 |
| Estimated completion | 2 August 2019 |
Drugs / interventions tested
- Serum insulin level
- Serum Leptin test
Conditions studied
- Pediatric Obesity — all drugs for Pediatric Obesity →
Sponsor
State University of New York at Buffalo
Who can join
Adults 8 to 14, any sex, with Pediatric Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will explore whether a relationship exists between insulin and leptin resistance, sweet taste responsiveness, and adiposity.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04600648
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pediatric Obesity
Currently open trials in the same condition.
- NCT06565455 — Growing Healthy Children and Families in Rural Arkansas · NA · recruiting
- NCT07342855 — Comparing Outcomes Among Children With Obesity in a Community Healthy Lifestyle Program · NA · recruiting
- NCT07095166 — Monitoring Eating Across Locations (MEAL) - Timing, Intake, and Mealtime Evaluation (TIME) · NA · recruiting
- NCT07229508 — Developmental Trajectories of Reinforcer Pathology and Childhood Obesity · recruiting
- NCT06572345 — Low EnerGy DiEt iN Adolescents With Obesity and Type 2 Diabetes: The LEGEND Study · NA · recruiting
Other State University of New York at Buffalo trials
Trials by the same sponsor.
- NCT07072767 — Hybrid Dissemination Study of A Digital-Analog Intervention to Increase Live Donor Kidney Transplantation · NA · not yet recruiting
- NCT07140848 — CGM-Enhanced DPP to Prevent Type 2 Diabetes in Adults With Prediabetes · NA · not yet recruiting
- NCT07433959 — Neuromodulation to Improve Grasping Function After SCI · NA · not yet recruiting
- NCT07403539 — Speech Learning and Speech Production in Parkinson's Disease · NA · recruiting
- NCT05367362 — Minocycline Efficacy in Improving Neurological Outcome of Patients Who Undergo Endovascular Revascularization for Acute · Phase 2 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04600648 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by State University of New York at Buffalo
- Last refreshed: 26 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04600648.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing